Bluesphere Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bluesphere Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$341K	Buy	694 +225	+48%	+$122K	0.12%	84
2025 Q4	$272K	Hold	469	–	–	0.12%	84
2025 Q3	$227K	Buy	+469	New	+$218K	0.1%	88
2025 Q2	–	Sell	-820	Closed	-$408K	–	95
2025 Q1	$408K	Sell	820 -229	-22%	-$124K	0.23%	53
2024 Q4	$546K	Hold	1,049	–	–	0.27%	52
2024 Q3	$649K	Hold	1,049	–	–	0.32%	44
2024 Q2	$580K	Hold	1,049	–	–	0.3%	44
2024 Q1	$610K	Hold	1,049	–	–	0.34%	41
2023 Q4	$557K	Hold	1,049	–	–	0.35%	43
2023 Q3	$531K	Hold	1,049	–	–	0.38%	38
2023 Q2	$547K	Hold	1,049	–	–	0.38%	36
2023 Q1	$605K	Hold	1,049	–	–	0.5%	34
2022 Q4	$578K	Sell	1,049 -25	-2%	-$13.2K	0.51%	37
2022 Q3	$545K	Hold	1,074	–	–	0.54%	35
2022 Q2	$583K	Hold	1,074	–	–	0.57%	32
2022 Q1	$634K	Hold	1,074	–	–	0.54%	36
2021 Q4	$717K	Hold	1,074	–	–	0.6%	35
2021 Q3	$614K	Sell	1,074 -100	-9%	-$54.9K	0.59%	33
2021 Q2	$592K	Hold	1,174	–	–	0.52%	35
2021 Q1	$536K	Buy	1,174 +250	+27%	+$119K	0.48%	40
2020 Q4	$430K	Buy	+924	New	+$433K	0.46%	43

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bluesphere Advisors's TMO Position: Q1 2026 in Review

Bluesphere Advisors increased its Thermo Fisher Scientific (TMO) stake by 48% in Q1 2026, buying an estimated $122K and bringing the position to 694 shares worth $341K. The position accounts for 0.12% of the portfolio, ranked #84.

Bluesphere Advisors first reported a position in TMO in Q4 2020 and has held it in 21 quarters since. The position peaked at $717K in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Bluesphere Advisors held 694 shares of Thermo Fisher Scientific worth $341K as of Q1 2026.
Bluesphere Advisors bought 225 Thermo Fisher Scientific shares in Q1 2026, an estimated $122K.
Thermo Fisher Scientific made up 0.12% of Bluesphere Advisors's portfolio in Q1 2026, its #84 holding.
Bluesphere Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 21 quarters since.
Bluesphere Advisors's Thermo Fisher Scientific position peaked at $717K in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Bluesphere Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.